Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease.
Yifei LiuJoakim SöderbergJingdong ChaoPublished in: Pharmacy (Basel, Switzerland) (2022)
The adherence rate to adalimumab therapy was 89% and the one-year persistence rate was 70%. The pen and treatment in a gastroenterology center had a positive impact on the adherence and persistence among Swedish patients with CD.